HOME >> BIOLOGY >> NEWS
Profiling amniotic fluid yields faster test for infection and preterm birth risk, researchers find

Researchers at the 26th Annual Society for Maternal-Fetal Medicine (SMFM) meeting today announced that profiling certain proteins in amniotic fluid is the fastest and most accurate way to detect potentially dangerous infections in pregnant women, and also can accurately predict whether premature delivery is imminent.

Diagnosing intra-amniotic inflammation or infection is crucial because these conditions can lead to the death of the fetus or other serious consequences of preterm birth, including brain damage, lung and bowel injury.

The study's authors were recognized by an award from the March of Dimes, marking the third year that the organization has honored SMFM members for cutting-edge prematurity research. The March of Dimes is conducting a multi-year, multi-million-dollar campaign aimed at reducing the growing rate of premature births through research and awareness.

"Our goal was to create a test that could more accurately predict which pregnancies with preterm labor are at risk for fetal complications from intrauterine inflammation/infection," said Catalin S. Buhimschi, M.D., of Yale University, the lead study author and SMFM member. "We found that profiling the proteins in amniotic fluid for markers of inflammation--a proteomic profile--not only yielded results twice as fast as other tests, but those results were also much more accurate. We discovered that the presence of fewer than two biomarkers for inflammation meant the median time for delivery was five to six days. If all the biomarkers for inflammation were present, delivery time was within hours."

"Research such as this is vital if we are to understand the basic mechanisms underlying preterm birth and find ways to prevent or treat it," said Nancy S. Green, M.D., medical director of the March of Dimes. "Dr. Buhimschi's work is exciting because it offers a potential new tool to identify women who are at highest risk for a preterm delivery. For these women, knowing the
'"/>

Contact: Sanda Pecina
202-367-1622
March of Dimes Birth Defects Foundation
2-Feb-2006


Page: 1 2

Related biology news :

1. Profiling of cancer genes may lead to better and earlier detection
2. Molecular Profiling Institute, Inc. acquires NanoBiomics, Inc.
3. The Molecular Profiling Institute, Inc. launches MammaPrint for breast cancer patients
4. The Molecular Profiling Institute named US provider of genetic breast cancer test
5. New proteomic method to detect inflammation in amniotic fluid
6. Cells from amniotic fluid used to tissue-engineer a new trachea
7. Protein analysis of amniotic fluid reveals clues about preterm birth
8. Researchers find new technique to identify fetal genetic material from amniotic fluid
9. Antibody linked to MS significantly higher in spinal fluid of blacks
10. Research on microfluidics widens the possibilities for electronic devices
11. Laser goes tubing for faster body-fluid tests

Post Your Comments:
(Date:2/25/2015)... ROCK, Ark. , Feb. 25, 2015 /PRNewswire/ ... software and billing in the Health and Fitness ... as well as to MYiCLUBonline.  The latest upgrade ... and the inclusion of cardless check-in via Identity ... for the first time through interactive displays at ...
(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/12/2015)... Minn. , Feb. 12, 2015   ... company specializing in clinical study management systems, has ... Program , further distinguishing iMedNet ... Clinical Research Organizations (CROs) and healthcare consultants.  Building ... support, prospective customer referrals and numerous co-marketing opportunities), ...
Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
(Date:3/6/2015)... Die SARAH-Studie ... Assistance Publique - Hôpitaux de ... französische, gemeinschaftliche, randomisierte Kontrollstudie für die mehr ... werden Patienten mit fortgeschrittenem hepatozellulärem Karzinom (HCC), ... behandelt wurden. Die Ergebnisse werden für Ende ...
(Date:3/5/2015)... , March 5, 2015   HX360 ... semi-finalists in the HX360 Innovation Challenge competition. ... will compete to be chosen as one of four ... of senior health system executives and venture capitalists during ... Innovation Challenge takes place at the 2015 HIMSS Annual ...
(Date:3/5/2015)... Altamonte Springs, FL (PRWEB) March 05, 2015 ... Jamie Damm for the position of Vice President of ... support managed care relationships for one of the nation’s ... Seattle, brings more than 15 years of specialty pharmacy ... Previously Damm worked with Raptor Pharmaceuticals, Vertex Pharmaceuticals, and ...
(Date:3/5/2015)... TORONTO , March 5, 2015 /PRNewswire/ - Aptose ... developing new therapeutics and molecular diagnostics that target the ... G. Rice , Ph.D., Chairman, President and Chief Executive ... Conference on Tuesday, March 10 th at 9:30 ... Laguna Niguel, CA. Dr. Rice will provide ...
Breaking Biology Technology:Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 2Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 3Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 4Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 5Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 6HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 2HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 3HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 4BioPlus Specialty Pharmacy Announces Hiring of New Vice President of Managed Care: Jamie Damm 2Aptose Biosciences to Present at the 27th Annual ROTH Conference 2Aptose Biosciences to Present at the 27th Annual ROTH Conference 3
Cached News: